相关实验视频
Updated: May 6, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.6K
查加斯心肌病和心脏起器患者的死亡风险评分
Giselle de Lima Peixoto1, Sérgio Freitas de Siqueira1, Silvana Angelina D'Orio Nishioka1
1Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil.
PLoS neglected tropical diseases
|May 9, 2024
概括
这项研究确定了患有心脏起器的慢性查加斯性心肌病 (CCC) 患者死亡的关键预测因素,并制定了验证的风险评分来评估死亡风险. 这些发现有助于对患者进行分层,以更好地管理这种复杂的心脏疾病.
科学领域:
- 心脏病学 心脏病学
- 流行病学 流行病学
- 医疗信息学 医疗信息学
背景情况:
- 慢性查加斯性心肌病 (CCC) 的预后受临床和功能因素的影响.
- 需要心脏起器植入的布拉迪心律失常是CCC患者经常出现的并发症.
- 对于带有心脏起器的CCC患者的死亡风险因素和预后尚不清楚.
研究的目的:
- 在大量带有心脏起器的CCC患者中确定所有原因死亡率的预测因素.
- 开发和验证一个风险评分来预测这种特定患者群体的死亡率.
主要方法:
- 采用了一个观察性,单心的,前性研究设计.
- 考克斯回归分析被用来确定死亡率预测因素.
- 开发了一个风险评分,并使用启动程序内部验证.
主要成果:
- 死亡率的预测因素包括右心室功能障碍,心力衰竭 (NYHA III/IV类),脏疾病,左心室末缩直径>44mm,心房动和心脏巨变.
- 创建了一个风险评分,将患者分为低风险,中等风险和高风险组.
- 预测模型表现出良好的表现,乐观度纠正的C统计值为0.751和校准斜率为0.946.
结论:
- 这项研究成功地确定了带有心脏起器的CCC患者死亡率的显著预测因素.
- 为这一群体开发了一个简单,验证和特定风险评分.
- 这些发现有助于对需要起器的CCC患者的风险分层和管理.
相关概念视频
Cardiomyopathy I: Introduction and Classification
837
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
837
Cardiomyopathy II: Dilated Cardiomyopathy
802
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy III: Hypertrophic Cardiomyopathy
812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy IV: Restrictive Cardiomyopathy
968
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
968
Cardiomyopathy V: Interprofessional Care
762
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762
Cardiomyopathy VI: Nursing Management
485
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
485

